Deals Who’s investing where? Private equity deal activity in the pharmaceutical industry in North America decreased by 30% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in Europe decreased by 37% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in The UK decreased by 24% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in Asia-Pacific decreased by 31% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in North America decreased by 7% in Q1 2023
Deals Who’s investing where? Private equity deal activity in the pharmaceutical industry in Europe decreased by 29% in Q1 2023
Deals Who’s investing where? Private equity deal activity in the pharmaceutical industry in Asia-Pacific decreased by 20% in Q1 2023
Deals Who’s investing where? Private equity deal activity in the pharmaceutical industry in India remained flat in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in China decreased by 33% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in The US decreased by 4% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in India decreased by 14% in Q1 2023
Deals Who’s investing where? Private equity deal activity in the pharmaceutical industry in The US decreased by 27% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in Japan decreased by 5% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in Middle East and Africa increased by 100% in Q1 2023
Deals Who’s acquiring who? M&A activity in the pharmaceutical industry in South and Central America increased by 38% in Q1 2023
Filings Who’s saying what? Orphan Designated Drugs mentions in company filings of pharmaceutical industry decreased by 18% in Q1 2023
Filings Who’s saying what? Regenerative Medicine mentions in company filings of pharmaceutical industry decreased by 24% in Q1 2023
Filings Who’s saying what? Virtual Care mentions in company filings of pharmaceutical industry decreased by 38% in Q1 2023
Filings Who’s saying what? Big Data mentions in company filings of pharmaceutical industry decreased by 13% in Q1 2023
Filings Who’s saying what? Blockchain mentions in company filings of pharmaceutical industry increased by 17% in Q1 2023
Filings Who’s saying what? Future of Work mentions in company filings of pharmaceutical industry decreased by 27% in Q1 2023
Filings Who’s saying what? Microbiome mentions in company filings of pharmaceutical industry decreased by 30% in Q1 2023
Deals Who’s acquiring who? Virtual care M&A activity in the pharmaceutical industry increased by 100% in Q1 2023
Deals Who’s acquiring who? Immuno-oncology M&A activity in the pharmaceutical industry decreased by 8% in Q1 2023
Deals Who’s acquiring who? Orphan designated drugs M&A activity in the pharmaceutical industry decreased by 23% in Q1 2023
Patents Who’s innovating where? Environmental sustainability related patent filings activity decreased by 23% in the pharmaceutical industry in Q1 2023
Jobs Who’s hiring who? Social Responsibility hiring activity decreased by 38% in the pharmaceutical industry in Q1 2023
Social Media Artificial Intelligence related social media posts increased by 32% in the pharma industry in Q1 2023
Social Media Who’s posting what? COVID-19 related social media posts decreased by 20% in the pharma industry in Q1 2023
Social Media Internet of Things related social media posts decreased by 9% in the pharma industry in Q1 2023
Filings Cybersecurity mentions in company filings of pharmaceutical industry increased by 113% in Q1 2023
Filings Who’s saying what? Environmental sustainability mentions in company filings of pharmaceutical industry increased by 114% in Q1 2023
Filings Who’s saying what? Corporate governance mentions in company filings of pharmaceutical industry increased by 141% in Q1 2023
Filings Who’s saying what? Social responsibility mentions in company filings of pharmaceutical industry increased by 104% in Q1 2023
Filings Artificial Intelligence mentions in company filings of pharmaceutical industry increased by 190% in Q1 2023